[
    [
        {
            "time": "",
            "original_text": "【浙商医药|周报】持续推荐业绩确定性高CXO板块，关注疫苗板块进展",
            "features": {
                "keywords": [
                    "CXO板块",
                    "疫苗",
                    "业绩确定性"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【浙商医药|周报】持续推荐业绩确定性高CXO板块，关注疫苗板块进展",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "财报解读 | 生物谷：两年“失血”产品单一 为“零人”公司创造上千万收入",
            "features": {
                "keywords": [
                    "生物谷",
                    "财报",
                    "失血",
                    "产品单一"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财报解读 | 生物谷：两年“失血”产品单一 为“零人”公司创造上千万收入",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药产业发展趋势下，四个投资方向被看好",
            "features": {
                "keywords": [
                    "医药产业",
                    "投资方向",
                    "趋势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药产业发展趋势下，四个投资方向被看好",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "如果散户不肯卖出股票，主力会通过这4种骗线对付散户，反复熟记7种“真假突破形态”，别再交出廉价筹码",
            "features": {
                "keywords": [
                    "散户",
                    "主力",
                    "骗线",
                    "突破形态"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "如果散户不肯卖出股票，主力会通过这4种骗线对付散户，反复熟记7种“真假突破形态”，别再交出廉价筹码",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "对话基金经理系列 | 前海联合林材：优选景气行业，精选具备核心竞争力的优质股",
            "features": {
                "keywords": [
                    "基金经理",
                    "景气行业",
                    "核心竞争力",
                    "优质股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "对话基金经理系列 | 前海联合林材：优选景气行业，精选具备核心竞争力的优质股",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健之佳二度冲刺IPO 公司第三大股东引得监管一再“关注”",
            "features": {
                "keywords": [
                    "健之佳",
                    "IPO",
                    "大股东",
                    "监管关注"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药零售"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "健之佳二度冲刺IPO 公司第三大股东引得监管一再“关注”",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]